BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37649294)

  • 1. Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.
    Niwa T; Tani M; Suzuki A; Murakami M
    Drug Metab Bioanal Lett; 2023; 16(2):73-80. PubMed ID: 37649294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A Subfamilies.
    Niwa T; Toyota M; Kawasaki H; Ishii R; Sasaki S
    Biol Pharm Bull; 2021; 44(4):579-584. PubMed ID: 33790108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.
    Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S
    Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic Activities Catalyzed by Human Cytochrome P450 (CYP) 2D6 and CYP3A Subfamily Members and Effect of Various Compounds, Including Endogenous Steroid Hormones, on These Activities].
    Niwa T
    Yakugaku Zasshi; 2024; 144(2):197-202. PubMed ID: 38296497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5.
    Niwa T; Narita K; Okamoto A; Murayama N; Yamazaki H
    J Pharm Pharm Sci; 2019; 22(1):332-339. PubMed ID: 31339834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the human cytochrome P450 2C subfamily to the metabolism of and the interactions with endogenous compounds including steroid hormones.
    Niwa T; Yasuda S; Yamamoto Y; Murakami M; Ishii R
    Pharmazie; 2021 Dec; 76(12):611-613. PubMed ID: 34986958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
    Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
    Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective hydroxylation of steroid hormones by human cytochromes P450.
    Niwa T; Murayama N; Imagawa Y; Yamazaki H
    Drug Metab Rev; 2015 May; 47(2):89-110. PubMed ID: 25678418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thin-Layer Chromatography Analysis of Human CYP3A-Catalyzed Testosterone 6β-Hydroxylation.
    Waxman DJ; Chang TK
    Methods Mol Biol; 2006; 320():133-141. PubMed ID: 27699667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inhibition of CYP3A subfamilies by macrolide antibiotics and piperine.
    Niwa T; Ishii R
    Drug Metab Bioanal Lett; 2022 Aug; ():. PubMed ID: 36043771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone.
    Kamdem LK; Meineke I; Koch I; Zanger UM; Brockmöller J; Wojnowski L
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):71-7. PubMed ID: 15232676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus.
    Ohmori S; Fujiki N; Nakasa H; Nakamura H; Ishii I; Itahashi K; Kitada M
    Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):15-28. PubMed ID: 9644715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.
    Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo.
    Peng CC; Templeton I; Thummel KE; Davis C; Kunze KL; Isoherranen N
    Clin Pharmacol Ther; 2011 Jun; 89(6):888-95. PubMed ID: 21490593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meclizine, a pregnane X receptor agonist, is a direct inhibitor and mechanism-based inactivator of human cytochrome P450 3A.
    Foo WY; Tay HY; Chan EC; Lau AJ
    Biochem Pharmacol; 2015 Oct; 97(3):320-30. PubMed ID: 26239802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.
    Kandel SE; Han LW; Mao Q; Lampe JN
    Drug Metab Dispos; 2017 Dec; 45(12):1266-1275. PubMed ID: 28986474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers.
    Lee J; Yoon SH; Yi S; Kim AH; Kim B; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):247-252. PubMed ID: 31088714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
    Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH
    Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.